Long-term growth and final adult height outcome in childhood-onset systemic lupus erythematosus

Table 4 Predictors of growth impairment between male and female cSLE patients

Predictive factors	Univariate		Multivariate
Predictive factors	OR (95%CI)	P value	OR (95%CI)	P value
Male patients (N = 19)
Age < 13 years	8.17 (1.03–64.94)	0.047^a	7.89 (0.62–100.89)	0.112
Cumulative dose of corticosteroids ≥330 mg/kg^b	18.0 (1.50–216.62)	0.023^a	6.99 (1.63–30.02)	0.009^a
Female patients (N = 87)
Age < 12 years	4.26 (1.31–13.90)	0.016^a	4.88 (1.39–17.13)	0.013^a
Height impairment at the diagnosis^c	4.13 (1.21–14.14)	0.024^a	4.92 (1.30–18.72)	0.030^a

^aP < 0.05 was set as significance; ^bPrednisolone equivalent; ^cHeight impairment at the diagnosis: height Z-score less than −1.5

ISSN: 1546-0096